Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation
Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement.Téléchargez la présentation en cliquant sur ce lien.Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.
1767 1602 1703 1564 1464 1477 1377 1457 1368 1229 1089 922 708 418 189 83 15 46 13 NUMBER OF LUNG TRANSPLANTS REPORTED BY YEAR AND PROCEDURE TYPE NOTE: This figure includes only the lung transplants that are reported to the ISHLT Transplant Registry. As such, this should not be construed as representing changes in the number of lung transplants performed worldwide. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival by Era (Transplants: January 1988 – June 2003) Survival comparisons by era 1988-94 vs. 1995-99: p = 0.01 1988-94: vs. 2000-6/03: p <0.0001 1995-99 vs. 2000-6/03: p <0.0001 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis(Transplants: January 1994 – June 2003) Survival comparisons COPD vs. IPF: p < 0.0001 Alpha-1 vs. CF: p = 0.0248 Alpha-1 vs. IPF: p < 0.0001 Alpha-1 vs. PPH: p = 0.0021 CF vs. COPD: p = 0.0006 CF vs. IPF: p < 0.0001 CF vs. PPH: p < 0.0001 CF vs. Sarcoidosis: p = 0.0007 Note: Other comparisons are not statistically different. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 3 Months(Transplants: January 1994 – June 2003) Survival comparisons Alpha-1 vs. IPF: p = 0.0015 Alpha-1 vs. COPD: p = 0.0073 CF vs. COPD: p < 0.0001 CF vs. IPF: p < 0.0001 PPH vs. COPD: p = 0.0005 PPH vs. IPF: p = 0.0002 Note: Other comparisons are not statistically different. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Diagnosis Conditional on Survival to 1 Year(Transplants: January 1994 – June 2003) Survival comparisons Alpha-1 vs. IPF: p = 0.0103 Alpha-1 vs. COPD: p < 0.0001 CF vs. COPD: p < 0.0001 CF vs. IPF: p = 0.0012 PPH vs. COPD: p < 0.0001 PPH vs. IPF: p = 0.0017 COPD vs. Sarcoidosis: p = 0.0102 IPF vs. Sarcoidosis: p = 0.0408 Note: Other comparisons are not statistically different. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival for Eisenmenger’s Syndrome(Transplants: January 1990 – June 2003) N at risk at 5 years = 33 N at risk at 5 years = 15 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type (Transplants: January 1990 – June 2003)Diagnosis: Alpha-1 Antitrypsin Deficiency P = 0.0007 N at risk at 10 years is 44 for Single Lung and 23 for Double Lung. ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982
ADULT LUNG TRANSPLANTATIONKaplan-Meier Survival By Procedure Type and Median Age (Transplants: January 1990 – June 2003)Diagnosis: Alpha-1 Antitrypsin Deficiency p = 0.22 N at risk at 5 years: Single Lung, <50 = 140; Double Lung, <50 = 126; Single Lung, 50+ = 97; Double Lung, 50+ = 45 ISHLT 2005 J Heart Lung Transplant 2005;24: 945-982